Yijia Luo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Yijia Luo has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Guijuan He
School of Nursing, Zhejiang Chinese Medical University, Hangzhou, China
3 shared publications - Jiayi Hou
Zhejiang Chinese Medical University
3 shared publications - Peimeng Teng
Zhejiang Chinese Medical University
2 shared publications - Yuyuan Han
Zhejiang Chinese Medical University
2 shared publications Peimeng Teng
Nursing School of Zhejiang Chinese Medical University Hangzhou Zhejiang China
1 shared publication- Qiqi Ni
Nursing Department Sir Run Run Shaw Hospital School of Medicine Zhejiang University Hangzhou Zhejiang China
1 shared publication
Latest Publications
- Top Cited PapersOpen Access
- 5 January 2026
- Published by SAGE Publications in Digital Health
- Vol. 12
Application of chatbots in chronic disease management: A scoping review
Background: Chatbots have been extensively utilized in chronic disease management to collect real-time health data, deliver personalized educational content, and guide self-management. Nevertheless, critical research gaps persist regarding their differential implementation across specific contexts and quantified comparative effectiveness. Objective: To synthesize existing research on the application of chatbots in chronic disease management, providing evidence-based insights to inform future clinical practice. Methods: Following Arksey and O’Malley's framework, we systematically searched eight databases from their inception until October 20, 2024. Relevant data were extracted from eligible studies, with a focus on disease areas, application platforms, interaction methods, technical architectures, implementation elements, and evaluation indicators. The findings were then synthesized and analyzed to identify key trends and gaps in the literature. Results: A total of 19 studies were included in this review, comprising 10 randomized controlled trials (RCTs) and 9 quasi-experimental studies. The investigated chronic conditions encompassed cancer, diabetes, hypertension, and other prevalent chronic diseases. Chatbot deployment platforms primarily included mobile applications, web-based platforms, and instant messaging software. The underlying technical architectures consisted of artificial intelligence-driven systems, rule-based systems, and hybrid models. The implementation strategies were categorized into night key dimensions. The predominant interaction modality was hybrid, with communication content focusing on self-management education, emotional support, and related domains. Outcome measures evaluated health-related indicators and user adherence indicators. Conclusions: Chatbots hold considerable clinical application value in chronic disease management. However, current research has some limitations. Future research should further optimize interaction design, refine system functionalities, and fortify privacy protection measures to better facilitate the integration of chatbots into chronic disease management.
- 5 January 2026
- Published by SAGE Publications in Digital Health
- Vol. 12
Top Cited PapersOpen AccessApplication of chatbots in chronic disease management: A scoping review
Background: Chatbots have been extensively utilized in chronic disease management to collect real-time health data, deliver personalized educational content, and guide self-management. Nevertheless, critical research gaps persist regarding their differential implementation across specific contexts and quantified comparative effectiveness. Objective: To synthesize existing research on the application of chatbots in chronic disease management, providing evidence-based insights to inform future clinical practice. Methods: Following Arksey and O’Malley's framework, we systematically searched eight databases from their inception until October 20, 2024. Relevant data were extracted from eligible studies, with a focus on disease areas, application platforms, interaction methods, technical architectures, implementation elements, and evaluation indicators. The findings were then synthesized and analyzed to identify key trends and gaps in the literature. Results: A total of 19 studies were included in this review, comprising 10 randomized controlled trials (RCTs) and 9 quasi-experimental studies. The investigated chronic conditions encompassed cancer, diabetes, hypertension, and other prevalent chronic diseases. Chatbot deployment platforms primarily included mobile applications, web-based platforms, and instant messaging software. The underlying technical architectures consisted of artificial intelligence-driven systems, rule-based systems, and hybrid models. The implementation strategies were categorized into night key dimensions. The predominant interaction modality was hybrid, with communication content focusing on self-management education, emotional support, and related domains. Outcome measures evaluated health-related indicators and user adherence indicators. Conclusions: Chatbots hold considerable clinical application value in chronic disease management. However, current research has some limitations. Future research should further optimize interaction design, refine system functionalities, and fortify privacy protection measures to better facilitate the integration of chatbots into chronic disease management.
- Open Access
- 1 January 2026
- Published by Wiley in Journal of Nursing Management
- Vol. 2026 (1) , 2615031
Effects of an EMAC Comprehensive Intervention Programme on Poststroke Depression: A Quasi‐Experimental Study
Aim: Evaluate the efficacy and safety of EMAC comprehensive intervention programme for poststroke depression patients. Background: Poststroke depression has a high incidence and significant adverse impacts. Pharmacological treatments for PSD carry certain risks. However, there is currently a lack of a comprehensive, evidence‐based nonpharmacological intervention programme for PSD in China. Methods: Between May to October 2024, we recruited patients with first‐onset stroke complicated by poststroke depression through convenience sampling from a tertiary hospital in Zhejiang Province. Participants were allocated to the EMAC intervention group and the conventional care control group according to their order of enrolment. This programme incorporated four key components: structured health education, mindfulness‐based stress reduction training, behavioral activation techniques, and standardised cognitive training. ANCOVA was used to compare the primary outcome between groups while adjusting for baseline scores and repeated‐measures analysis of variance was applied to analyze secondary outcomes across the three assessment points. Measures: The primary outcome of this study was the change in depressive symptoms measured using the HAMD‐17. Secondary outcomes included the five facet mindfulness questionnaire, behavioral activation for depression scale–short form, Montreal Cognitive Assessment, stroke‐specific quality of life scale, and records of adverse event frequency. Results: Compared with the control group, participants receiving the EMAC programme had significantly lower adjusted HAMD‐17 scores at T1 (10.632 [95% CI, 10.119–11.146] vs. 12.112 [95% CI, 11.611–12.613], p < 0.001) and T2 (9.344 [95% CI, 8.663–10.025] vs. 12.053 [95% CI, 11.388–12.718], p < 0.001). Secondary outcomes showed significant improvements over time in the intervention group compared with the control group ( p < 0.05). Conclusions: This programme can effectively improve the health outcomes of patients and provides valuable evidence and reference for clinical application and dissemination of the intervention. Implications for the Patient Care: The EMAC programme provides nurses with a practical, evidence‐based protocol for poststroke depression. It combines education, mindfulness, behavioral activation, and cognitive training and may provide a clear and replicable framework for supporting patients with poststroke depression. The observed improvements in depressive symptoms, cognitive function, and quality of life suggest its potential value in clinical nursing practice. Future studies may explore whether selected components of the programme can be adapted to digital platforms to improve accessibility and implementation efficiency. Trial Registration: Chinese Registry of Clinical Trials: ChiCTR2300070335
- 1 January 2026
- Published by Wiley in Journal of Nursing Management
- Vol. 2026 (1) , 2615031
Open AccessEffects of an EMAC Comprehensive Intervention Programme on Poststroke Depression: A Quasi‐Experimental Study
Aim: Evaluate the efficacy and safety of EMAC comprehensive intervention programme for poststroke depression patients. Background: Poststroke depression has a high incidence and significant adverse impacts. Pharmacological treatments for PSD carry certain risks. However, there is currently a lack of a comprehensive, evidence‐based nonpharmacological intervention programme for PSD in China. Methods: Between May to October 2024, we recruited patients with first‐onset stroke complicated by poststroke depression through convenience sampling from a tertiary hospital in Zhejiang Province. Participants were allocated to the EMAC intervention group and the conventional care control group according to their order of enrolment. This programme incorporated four key components: structured health education, mindfulness‐based stress reduction training, behavioral activation techniques, and standardised cognitive training. ANCOVA was used to compare the primary outcome between groups while adjusting for baseline scores and repeated‐measures analysis of variance was applied to analyze secondary outcomes across the three assessment points. Measures: The primary outcome of this study was the change in depressive symptoms measured using the HAMD‐17. Secondary outcomes included the five facet mindfulness questionnaire, behavioral activation for depression scale–short form, Montreal Cognitive Assessment, stroke‐specific quality of life scale, and records of adverse event frequency. Results: Compared with the control group, participants receiving the EMAC programme had significantly lower adjusted HAMD‐17 scores at T1 (10.632 [95% CI, 10.119–11.146] vs. 12.112 [95% CI, 11.611–12.613], p < 0.001) and T2 (9.344 [95% CI, 8.663–10.025] vs. 12.053 [95% CI, 11.388–12.718], p < 0.001). Secondary outcomes showed significant improvements over time in the intervention group compared with the control group ( p < 0.05). Conclusions: This programme can effectively improve the health outcomes of patients and provides valuable evidence and reference for clinical application and dissemination of the intervention. Implications for the Patient Care: The EMAC programme provides nurses with a practical, evidence‐based protocol for poststroke depression. It combines education, mindfulness, behavioral activation, and cognitive training and may provide a clear and replicable framework for supporting patients with poststroke depression. The observed improvements in depressive symptoms, cognitive function, and quality of life suggest its potential value in clinical nursing practice. Future studies may explore whether selected components of the programme can be adapted to digital platforms to improve accessibility and implementation efficiency. Trial Registration: Chinese Registry of Clinical Trials: ChiCTR2300070335
- 10 December 2025
- Published by Wiley in International Journal of Nursing Practice
- Vol. 31 (6) , e70084
The Clinical Efficacy of Direct Swallowing Training for Patients with Dysphagia: A Systematic Review
Aim: This review systematically evaluated the clinical effectiveness of direct swallowing training in patients with dysphagia. Background: Dysphagia has a high prevalence rate and can seriously impair patients' quality of life. Although direct swallowing training within current rehabilitation frameworks demonstrates efficacy, there remains a lack of standardised protocols and an absence of comprehensive systematic reviews that incorporate multidimensional outcome measures. Methods: Literature searches were conducted across CNKI, Wanfang Database, CBMdisc, PubMed, Web of Science, Embase, Cochrane Library, and CINAHL. The keywords employed included “Swallowing Training”, “Food Texture Modification”, “Deglutition Disorders” and “Nutritional Status”. The search period was from the establishment of each database to August 2025. Meta‐analyses were executed using RevMan software. Results: A total of 25 randomised controlled studies were included. The findings indicate that direct swallowing training significantly improves swallowing function, nutritional status, quality of life and reduces the incidence of complications in patients with dysphagia. Conclusion: This review supports the development of standardised protocols for direct swallowing training interventions, providing evidence‐based recommendations for clinical nursing practice aimed at optimising patient outcomes.
- 10 December 2025
- Published by Wiley in International Journal of Nursing Practice
- Vol. 31 (6) , e70084
The Clinical Efficacy of Direct Swallowing Training for Patients with Dysphagia: A Systematic Review
Aim: This review systematically evaluated the clinical effectiveness of direct swallowing training in patients with dysphagia. Background: Dysphagia has a high prevalence rate and can seriously impair patients' quality of life. Although direct swallowing training within current rehabilitation frameworks demonstrates efficacy, there remains a lack of standardised protocols and an absence of comprehensive systematic reviews that incorporate multidimensional outcome measures. Methods: Literature searches were conducted across CNKI, Wanfang Database, CBMdisc, PubMed, Web of Science, Embase, Cochrane Library, and CINAHL. The keywords employed included “Swallowing Training”, “Food Texture Modification”, “Deglutition Disorders” and “Nutritional Status”. The search period was from the establishment of each database to August 2025. Meta‐analyses were executed using RevMan software. Results: A total of 25 randomised controlled studies were included. The findings indicate that direct swallowing training significantly improves swallowing function, nutritional status, quality of life and reduces the incidence of complications in patients with dysphagia. Conclusion: This review supports the development of standardised protocols for direct swallowing training interventions, providing evidence‐based recommendations for clinical nursing practice aimed at optimising patient outcomes.